HealthEconomics.Com - The Resource for Health Outcomes Professionals

search   
Sign Up For Our Newsletter
Email:  


industry news

Health Care Reform — Where Do We Go from Here?

"Interpreting Hazards: The Increasing Importance of "Antidote to Anecdote" in Managed Care" by Fairman et al

"Is "Value-Based" Value Wasted? Examining Value-Based Insurance Designs Through the Lens of Cost-Effectiveness" by Melnick et al

58% of Surgeries Performed in Hospitals are Outpatient, According to AHRQ/HCUP survey.

AHRQ Introduces New Online Technical Tutorial Series With First Module on HCUP Sample Design

Doctors Face 21% Cut In Medicare Payments.

AMCP Issues Summary of White House Health Care Reform Summit

Maximus To Continue Reviewing Medicare Part D Plan Coverage Determinations

Pharmacoeconomics to Get Bigger Budgets, According to Preliminary Survey Results (Source=Marketwire)

Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50,000 Threshold in the US by Bridges et al.

The AMCP Format for Formulary Submissions, Version 3.0

Statistical Data Resources from AMCP for benchmarking in managed care

UnitedHealthcare has launched an innovative program that offers $20 discounts off certain prescription drug co-payments

Healthcare Technology News: National Health Expenditures Top 17% of GDP

UnitedHealthcare Creates Adult National Cancer Care Registry with Data and Analysis to Support Oncologists in the Fight against Cancer

Novartis’s Afinitor Cancer Drug Rejected by U.K. Cost Agency

NEJM: “Giving Teeth to Comparative-Effectiveness Research — The Oregon Experience” by Saha et al.

Oncology Innovative Pricing deal with NICE on lung cancer drug

“Medication Adherence and Enrollment in a Consumer-Driven Health Plan” by Chen,

FDA News: NICE Outlines Appeals Process for Drug Determinations

IBI: More Than Health Promotion: How Employers Manage Health and Productivity

PR Hub: NICE Recommends Approval of New Rheumatoid Arthritis (RA) Treatment Cimzia(R) (certolizumab pegol) With First of its Kind RA Patient Access Scheme

Healthcare Technology News: Privacy Survey - In Providers We Trust

NEJM article: ‘ Uncomfortable Arithmetic — Whom to Cover versus What to Cover’ by K. Baicker and A. Chandra

NEJM article: ‘ “Play-or-Pay” Insurance Reforms for Employers — Confusion and Inequity’ by B. Herring and M.V. Pauly

Centre for Reviews and Dissemination: Cost-effectiveness of interventions to promote physical activity: a modelling study

Do Health Politicians Really Listen to Health Economists? Observations from Europe by Mittendorf et al.

The Hospitalist: Evidence-Based Medicine Curveball

Health Care Reform and the Need for Comparative-Effectiveness Research

January 2010 Newsletter and Eisenberg Conference Series 2009 Are Now Available

Disease Management Care Blog: 10 Predictions for the Next Decade

Managed Care Vendor Sales Insight Article: Blue Cross Plans Join Initiative To Increase Transparency

Conference: Patient Experience and Patient Safety Culture, April 19-21

Funny Pharmacy Videos. These are Hysterical! Particularly "The PharmG's - Boom Intervention" Rap


hot jobs

Job Title Company
Health Economics and Outcomes Research Project Manager Creativ-Ceutical
Director Healthcare Economics Medtronic
Faculty, Healthcare and Pharmacy Administration Albany College of Pharmacy & Health Sciences
Health Economist University of Cambridge, Institute of Public Health
DIRECTOR-ONCOLOGY, GHEOR Bristol-Myers Squibb


pharmacy/biotech companies

Abbott
Accentia Biopharmaceuticals
Access Pharmaceuticals, Inc.
Advanced Neuromodulation Systems, Inc.
Aeolus Pharmaceuticals
Alcon Laboratories, Inc.
Alexion Pharmaceuticals
Allergan
Alliance Pharmaceutical Corp.
Alpharma Inc.
Alphatec Manufacturing, Inc.
Altana (Now Nycomed)
Alteon, Inc. (Now Synvista Ther.)
Amarillo Biosciences
Ambrilia BioPharma
American Medical Systems (AMS), Inc.
Amgen, Inc.
Amylin Pharmaceuticals
Angeion
Antigenics, LLC
Antisoma
Aradigm Corporation
Ardea Biosciences
Astellas Pharma US, Inc.
AstraZeneca
AutoImmune, Inc.
Avanir Pharmaceuticals
Avant Immunotherapeutics, Inc.
AVAX Technologies, Inc.
AVI BioPharma
Avigen Inc.
Axcan Scandipharm, Inc.
Axys Pharmaceuticals
Bard
BASF
BASF Pharma
Bausch & Lomb
Baxter
Bayer (U.S.)
BD (Becton, Dickinson and Company)
Beckman Coulter
Berlex
Now integrated into Bayer HealthCare and operating under the new name Bayer HealthCare Pharmaceuticals
Biogen Idec
Biomira Inc.
Renamed as Oncothyreon
Bioniche Life Sciences Inc.
Biopure Biopharmaceuticals
BioSpecifics Technologies Corp.
Biota Holdings Ltd.
BioTime, Inc.
Biotronik Biomedical
BioZone Laboratories
Boehringer Ingelheim
Book: Best Practices in Biotechnology Business Development
By Yali Friedman. Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
Boston Scientific
Bradley Pharmaceuticals, Inc.
Now renamed as PharmDerm
Bristol Myers Squibb
Calypte Biomedical
Cangene Corporation
Cardium Therapeutics
Caridian BCT
Celgene Corporation
Cell Genesys, Inc.
Celltech Group (part of UCB)
CEL-SCI Corporation
CeNeS Pharmaceuticals
Now a part of Paion AG
Centocor, Inc.
Cephalon, Inc.
Cerus Corporation
Chiron Corporation (part of Novartis)
CIBA Vision (part of Novartis)
Closure Medical (Now part of Ethicon)
COBE Cardiovascular, Inc. (Now Sorin Group)
Cohesion Technologies (Now Angiotech)
Connetics Corporation (Now Stiefel Labs)
Cortex Pharmaceuticals, Inc.
CTI (Cell Therapeutics Inc)
Cubist Pharmaceuticals, Inc.
Curis, Inc.
CV Therapeutics
Cygnus Technologies
Cypress Pharmaceutical, Inc.
Cytogen Corporation
CytRx Corporation
Cytyc (Now called as Hologic after merger with Hologic)
Daiichi Pharmaceutical Co., Ltd.
The US division
Dava Pharma
DEBIO
Delsite Inc. (Formerly Carrington Labs)
Dendreon Corporation
Dermik Laboratories (Part of Sanofi aventis)
DermTech International
Destiny Pharma
Devgen
Dey, Inc.
DiagnoCure
Digene Corp. (Now called Qiagen after merger with Qiagen)
Discovery Laboratories, Inc.
Draxis Health Inc.
DUSA Pharmaceuticals
Elan Corporation
Eli Lilly and Company
Encysive Pharmaceuticals
Endo Pharmaceuticals
Endovasc
Enzon Inc.
Epix Medical, Inc.
Ethex Corporation
EUROSCREEN
Exocell, Inc.
Ferring Pharmaceuticals
Forest Laboratories, Inc.
Galderma Laboratories
Gambro
Gambro Renal Products, Inc. (USA)
GE Healthcare (owner of Abbott
Genaera
Genentech
Genta Incorporated
GenVec, Inc.
Genzyme Biosurgery
Genzyme Oncology
Gilead Sciences
GSK (GlaxoSmithKline)
Healthpoint, Ltd.
Helsinn Healthcare S.A.
Hemagen Diagnostics, Inc.
Hemispherx BioPharma, Inc.
Hollis Eden Pharmaceuticals
Human Genome Sciences, Inc.
IBEX Technologies
ICOS Corporation (Part of Eli Lilly)
I-Flow Corporation
ImClone Systems, Inc.
Immunomedics, Inc.
IMPAX Laboratories, Inc.
Indevus Pharmaceuticals, Inc.
Integra LifeSciences Corporation
Intergen Company (Now Millipore)
InterMune Pharmaceuticals, Inc.
Intracel Corporation
Inverness Medical Professional Diagnostics
Inverness Medical-BioStar Inc.
Invitrogen
Isis Pharmaceuticals
IVP Pharmaceutical Care, Inc.
Janssen Pharmaceuticals
Jazz Pharmaceuticals
Johnson & Johnson
Kendall Company, L.P. (Now part of Covidien)
King Pharmaceuticals, Inc.
Kos Pharmaceuticals Inc.
Acquired by Abbott
KV Pharmaceutical Company
LifeCell Corporation
LifeLine BioTechnologies, Inc.
Ligand Pharmaceuticals
Lorus Therapeutics Inc.
MacroChem Corporation
Mallinckrodt
Matritech
Mead Johnson Nutritionals
Meda Pharmaceuticals
Medarex, Inc.
Medicare 2007 Outpatient Coding and Reimbursement Final Rule Changes
oin Healthcare Reimbursement Monitor and the reimbursement experts of BESLER Consulting, a leading advisory firm in healthcare financial management and operations, to get a better understanding of the new Medicare coding and reimbursement changes for OPPS and how it will impact your organization. This live 90-minute audio conference happened on December 7, 2006. Cost is $227 for CD+materials
Medicines Company
Medicis Pharmaceutical Corp.
MediGene AG
MedImmune, Inc.
Medtronic
Merck
Merck Serono
MGI Pharma, Inc. (Now part of Eisai Corp.)
Millennium Pharmaceuticals, Inc.
Monsanto
Mylan Laboratories Inc.
Myriad Genetics, Inc.
Nabi
Neurobiological Technologies, Inc.
Neurochem Inc. (Now Bellus Health)
NeuroMetrix
New England Biolabs
NexMed
Novartis
Novavax, Inc.
Noven Pharmaceuticals, Inc.
Novogen Limited
Novogyne Pharmaceuticals
Onconome Inc.
Operon Technologies, Inc.
Organogenesis, Inc.
Ortho-McNeil Pharmaceutical, Inc.
OSI Pharmaceuticals
Osiris Therapeutics, Inc.
Osteotech
Otsuka America Pharmaceutical, Inc.
Oxford BioMedica
Oxigene, Inc.
Paradigm Medical Industries, Inc.
Pfizer
Pharmaceutical Industry Info
List of Pharmaceutical Companies / Suppliers and Projects, Press Releases, News and Resources in our Directory.
Pharmalicensing.com
This knowledge packed resource, contains pipeline, financial, analytics, competitor, and partnering information on up to 10,000 biomedical companies worldwide.
Pharmos Corporation
Polydex Pharmaceuticals Ltd.
Poniard Pharmaceuticals
Procter & Gamble Pharmaceuticals
Progenics Pharmaceuticals
Promega Corporation
Protein Polymer Technologies, Inc.
Protherics
Purdue Pharma L.P.
Quest Medical, Inc.
Quidel Corporation
RatioPharm
Regeneron Pharmaceuticals, Inc.
Repros Therapeutics, Inc.
ResMed
Roche
Roche Pharmaceuticals (Hoffman-LaRoche)
Rochester Medical Corporation
Salix Pharmaceuticals (merged with InKine)
SaluMedica
Samaritan Pharmaceuticals
Sanofi Pasteur
Sanofi-Aventis
Santen Inc.
Savage Laboratories
Schein Pharmaceutical, Inc. (Now Watson Pharma)
Schering-Plough
Schwarz Pharma
SciClone Pharmaceuticals, Inc.
Scios Inc.
Senetek PLC
Sepracor
Sernova Corp.
Siemens Medical Solutions Diagnostics
Sirna Therapeutics
Skinvisible
SkyePharma PLC
Solvay Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc.
STERIS Corporation
SuperGen, Inc.
TAP Pharmaceutical Products, Inc. (Now part of Takeda Pharma)
Taro Pharmaceuticals, Inc.
Tekmira Pharma (Formerly Inex Pharmaceutical Corp.)
Teva Pharmaceutical Industries Ltd.
Therion Biologics
Thermo Scientific
ThermoGenesis
TherOx
Tissue Science Laboratories
TopGen Health Care / T.G. Pharma
T.G. Pharma is a subsidiary of TopGen Health Care Pvt. Ltd., and a leading, fast growing pharmaceutical company in Pakistan. It has a GMP compliant manufacturing facility in Karachi, Pakistan. T.G. Pharma has excellent capability of developing, manufacturing and marketing top quality generics. It has several old and new molecules in leading therapeutic classes. It has oral solid, liquid and injectable area, along with dedicated oral and injectable cephalosporin area. It also has cream/ ointment and ophthalmic products area.
TorreyPines Therapeutics
Trimeris, Inc.
Trinity Biotech
United Therapeutics Corp.
Upsher-Smith Laboratories
USB
Utah Medical Products
Vectura Group PLC (Formerly Innovata PLC)
Vertex Pharmaceuticals
Vion Pharmaceuticals, Inc.
ViroPharma Inc.
Vitro Biopharma
Vivus
Vysis, Inc.
Warner Chilcott, plc.
Watson Pharmaceuticals, Inc.
Wellness Incentives: Beyond Mugs and T-Shirts
Explore the types of wellness incentives that work to boost participation and, most importantly, health improvement in this special 90-minute audio conference that took place on January 25, 2007. Cost is $227 for CD + materials
Wyeth Pharmaceuticals
XOMA
Zenyth Therapeutics
Zila Pharmaceuticals, Inc.




 

Insurance Resources: Even healthy people need life insurance.
Get life insurance quotes today.

Shop and compare insurance quotes online

 

sponsored by































Become a sponsor



How are we doing? Take our survey





Copyright © 2007, HealthEconomics.Com